Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Dent

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
CJC Open|December 13, 2021
Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysisMuhammad Mustafa Alhussein, Abir Mokbel, Tammy Cosman, et al.
Journal of the National Cancer Institute|April 17, 2003
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancerTimothy Whelan, Carol Sawka, Mark Levine, et al.
International Journal of Cardiology|January 31, 2019
Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular eventsWilliam J Phillips, Christopher Johnson, Angeline Law, et al.
JACC. Cardiooncology|May 5, 2023
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewSusmita Parashar, Nausheen Akhter, Elisavet Paplomata, et al.
Clinical Pharmacokinetics|December 21, 2016
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionChunze Li, Priya Agarwal, Ekaterina Gibiansky, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
Myocardial Strain Measurements Obtained with Fast-Strain-Encoded Cardiac Magnetic Resonance for the Risk Prediction and Early Detection of Chemotherapy-Related Cardiotoxicity Compared to Left Ventricular Ejection FractionDaniel Lenihan, James Whayne, Farouk Osman, et al.
Zdravstveno Varstvo|December 17, 2021
Relationship Between Quality of Life Indicators and Cardiac Status Indicators in Chemotherapy PatientsBlaž Matija Geršak, Andreja Kukec, Henning Steen, et al.
Hypertension (Dallas, Tex. : 1979)|January 9, 2023
Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart AssociationJordana B Cohen, Nancy J Brown, Sherry-Ann Brown, et al.
Journal of the American Heart Association|July 26, 2024
Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous StudyOmar M Makram, Tochukwu Okwuosa, Daniel Addison, et al.
Circulation|February 9, 2026
Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart AssociationLili Zhang, Cezar Iliescu, Maros Ferencik, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
CJC Open|December 13, 2021
Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysisMuhammad Mustafa Alhussein, Abir Mokbel, Tammy Cosman, et al.
Journal of the National Cancer Institute|April 17, 2003
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancerTimothy Whelan, Carol Sawka, Mark Levine, et al.
International Journal of Cardiology|January 31, 2019
Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular eventsWilliam J Phillips, Christopher Johnson, Angeline Law, et al.
JACC. Cardiooncology|May 5, 2023
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewSusmita Parashar, Nausheen Akhter, Elisavet Paplomata, et al.
Clinical Pharmacokinetics|December 21, 2016
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionChunze Li, Priya Agarwal, Ekaterina Gibiansky, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
Myocardial Strain Measurements Obtained with Fast-Strain-Encoded Cardiac Magnetic Resonance for the Risk Prediction and Early Detection of Chemotherapy-Related Cardiotoxicity Compared to Left Ventricular Ejection FractionDaniel Lenihan, James Whayne, Farouk Osman, et al.
Zdravstveno Varstvo|December 17, 2021
Relationship Between Quality of Life Indicators and Cardiac Status Indicators in Chemotherapy PatientsBlaž Matija Geršak, Andreja Kukec, Henning Steen, et al.
Hypertension (Dallas, Tex. : 1979)|January 9, 2023
Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart AssociationJordana B Cohen, Nancy J Brown, Sherry-Ann Brown, et al.
Journal of the American Heart Association|July 26, 2024
Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous StudyOmar M Makram, Tochukwu Okwuosa, Daniel Addison, et al.
Circulation|February 9, 2026
Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart AssociationLili Zhang, Cezar Iliescu, Maros Ferencik, et al.
Pageof 13